Original investigation: dialysis therapy
Restless legs symptoms among incident dialysis patients: Association with lower quality of life and shorter survival

https://doi.org/10.1053/j.ajkd.2004.01.013Get rights and content

Abstract

Background: Symptoms of restless legs are common among patients treated with long-term hemodialysis. We investigated the relation between symptoms of restless legs, quality of life, and survival among incident hemodialysis and peritoneal dialysis patients. Methods: This report includes 894 dialysis patients who responded to an item regarding severity of restless legs symptoms in the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease Study. We examined participant responses both as categorized by the 5-point symptoms of restless legs item and classified with severe symptoms of restless legs if they reported they were very or extremely bothered by symptoms. Independent predictors of restless legs symptoms were estimated using logistic regression. The association of restless legs symptoms with quality of life was examined by means of mixed-model regression, and adjusted mortality risk was estimated by means of Cox proportional hazards. Results: Fifteen percent of dialysis patients were classified as having severe restless legs. Those characterized by severe restless legs were significantly more likely to be administered benzodiazepines, antidepressants, and antiepileptics. Age and diabetes mellitus were independently associated with severe symptoms of restless legs. Symptoms of restless legs were associated with lower Physical and Mental Component Scores, vitality, bodily pain, and sleep quality (all P < 0.001). After adjustment, severe symptoms of restless legs were significantly associated with an increased mortality hazard ratio of 1.39 (95% confidence interval, 1.08 to 1.79). Conclusion: Symptoms of restless legs were associated with lower quality of life and increased risk for death. The effect of treatment for symptoms of restless legs on quality of life and survival awaits additional study.

Section snippets

Study design and population

Study subjects were a subpopulation of patients participating in the CHOICE Cohort Study.12 CHOICE is a national prospective cohort study of incident hemodialysis and peritoneal dialysis patients initiated in 1995. From October 1995 to June 1998, a total of 1,041 patients (764 hemodialysis and 277 peritoneal dialysis patients) were enrolled from 80 dialysis clinics associated with Dialysis Clinic, Inc (Nashville, TN), New Haven CAPD (New Haven, CT), and the Hospital of St Raphael (New Haven,

Results

The CHOICE Cohort Study included 1,041 individuals. Patients were enrolled a median of 45 days from initiation of long-term dialysis therapy. Of these, 928 patients completed the CHEQ. Of patients who responded to the CHEQ, 894 patients (96.3%) completed the item about restless legs and comprised the sample of the present report. The 894 patients included in this study were more likely than the remaining 147 CHOICE patients to have white race (68.5% versus 57.5%; P = 0.03), more education

Discussion

In this study, 15% of patients beginning dialysis treatment for kidney failure reported severe symptoms of restless legs. The prevalence of these symptoms among peritoneal dialysis patients was similar to that among hemodialysis patients, and prevalence of symptoms did not vary by race of the respondent. Furthermore, severe restless legs symptoms were associated with substantially diminished physical functioning and mental well-being. Last, severe restless legs symptoms were independently

Acknowledgements

The authors thank the patients, staff, and physicians who participated in the CHOICE Study at Dialysis Clinic Inc, St Raphael's Hospital, and New Haven CAPD.

References (47)

  • P.L. Kimmel et al.

    ESRD patient quality of lifeSymptoms, spiritual beliefs, psychosocial factors, and ethnicity

    Am J Kidney Dis

    (2003)
  • M. Ferrara et al.

    The effects of slow-wave sleep (SWS) deprivation and time of night on behavioral performance upon awakening

    Physiol Behav

    (1999)
  • R.L. Benz et al.

    Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders

    Am J Kidney Dis

    (2000)
  • F. Lofaso et al.

    Sleep fragmentation as a risk factor for hypertension in middle-aged nonapneic snorers

    Chest

    (1996)
  • F. Lofaso et al.

    Arterial blood pressure response to transient arousals from NREM sleep in nonapneic snorers with sleep fragmentation

    Chest

    (1998)
  • N. Kutner et al.

    Restless legs complaint in African-American and Caucasian hemodialysis patients

    Sleep Med

    (2002)
  • M.L. Thorp et al.

    A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients

    Am J Kidney Dis

    (2001)
  • J.L. Holley et al.

    Characterizing sleep disorders in chronic hemodialysis patients

    ASAIO Trans

    (1991)
  • A.L. Chesson et al.

    Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine

    Sleep

    (1999)
  • A.S. Walters

    Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

    Mov Disord

    (1995)
  • B. Phillips et al.

    Epidemiology of restless legs symptoms in adults

    Arch Intern Med

    (2000)
  • H.M. Ruottinen et al.

    An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome

    Neurology

    (2000)
  • N. Powe et al.

    Choices for Health Outcomes in Caring for End-Stage Renal Disease

    Semin Dial

    (1996)
  • Cited by (182)

    • Renal disorders and sleep

      2023, Encyclopedia of Sleep and Circadian Rhythms: Volume 1-6, Second Edition
    • Restless legs syndrome in internal medicine

      2023, Encyclopedia of Sleep and Circadian Rhythms: Volume 1-6, Second Edition
    • Common Clinical Problems in Hemodialysis

      2022, Handbook of Dialysis Therapy
    View all citing articles on Scopus

    Supported in part by grant no. R01-HS-08365 from the Agency for Healthcare Research and Quality from June 1995 to May 2000 (CHOICE Study); grants no. R01-HL-62985, R01-DK-07024 (CHOICE Study), and K24-DK-02643 (N.R.P.) from the National Institute of Diabetes and Digestive and Kidney Diseases; and an American Society of Nephrology-Association for Subspecialty Professors Junior Development Grant in Geriatric Nephrology (M.L.U.).

    View full text